Published in J Virol on July 01, 2000
Efficient intracellular assembly of papillomaviral vectors. J Virol (2004) 5.36
Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J Virol (2001) 2.25
Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J Virol (2006) 1.92
Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin. J Virol (2005) 1.87
Life cycle heterogeneity in animal models of human papillomavirus-associated disease. J Virol (2002) 1.66
Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc Natl Acad Sci U S A (2006) 1.32
The papillomavirus E2 proteins. Virology (2013) 1.30
Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver. Proc Natl Acad Sci U S A (2003) 1.22
Replication and partitioning of papillomavirus genomes. Adv Virus Res (2008) 1.21
Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain. J Virol (2001) 1.19
Regulation of the EBNA1 Epstein-Barr virus protein by serine phosphorylation and arginine methylation. J Virol (2006) 1.16
Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4. J Virol (2009) 1.13
Interaction of the betapapillomavirus E2 tethering protein with mitotic chromosomes. J Virol (2010) 1.02
Brd4 regulation of papillomavirus protein E2 stability. J Virol (2009) 1.02
Conditional mutations in the mitotic chromosome binding function of the bovine papillomavirus type 1 E2 protein. J Virol (2005) 1.00
Tax1BP1 interacts with papillomavirus E2 and regulates E2-dependent transcription and stability. J Virol (2008) 0.97
Regulation of bovine papillomavirus replicative helicase e1 by the ubiquitin-proteasome pathway. J Virol (2002) 0.94
The human papillomavirus type 18 E2 protein is a cell cycle-dependent target of the SCFSkp2 ubiquitin ligase. J Virol (2010) 0.93
Phosphorylation regulates binding of the human papillomavirus type 8 E2 protein to host chromosomes. J Virol (2012) 0.92
E1 protein of bovine papillomavirus type 1 interferes with E2 protein-mediated tethering of the viral DNA to mitotic chromosomes. J Virol (2002) 0.92
Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression. Am J Cancer Res (2011) 0.91
Dimerization of the papillomavirus E2 protein is required for efficient mitotic chromosome association and Brd4 binding. J Virol (2008) 0.91
Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle. Viruses (2013) 0.89
Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs). Virology (2008) 0.89
The Role of the DNA Damage Response throughout the Papillomavirus Life Cycle. Viruses (2015) 0.89
Host cell sumoylation level influences papillomavirus E2 protein stability. Virology (2009) 0.85
Control the host cell cycle: viral regulation of the anaphase-promoting complex. J Virol (2013) 0.84
Topography of bovine papillomavirus E2 protein on the viral genome during the cell cycle. Virology (2009) 0.83
Genetic analysis of the E2 transactivation domain dimerization interface from bovine papillomavirus type 1. Virology (2013) 0.82
NRIP, a novel calmodulin binding protein, activates calcineurin to dephosphorylate human papillomavirus E2 protein. J Virol (2011) 0.82
A proteomic approach to discover and compare interacting partners of papillomavirus E2 proteins from diverse phylogenetic groups. Proteomics (2015) 0.80
Phosphorylation of HPV-16 E2 at serine 243 enables binding to Brd4 and mitotic chromosomes. PLoS One (2014) 0.79
Brd4 Activates Early Viral Transcription upon Human Papillomavirus 18 Infection of Primary Keratinocytes. MBio (2016) 0.79
Brd4-mediated nuclear retention of the papillomavirus E2 protein contributes to its stabilization in host cells. Viruses (2014) 0.79
CK2 phosphorylation inactivates DNA binding by the papillomavirus E1 and E2 proteins. J Virol (2013) 0.78
The Role of F-Box Proteins during Viral Infection. Int J Mol Sci (2013) 0.77
The role of ubiquitin and ubiquitin-like modification systems in papillomavirus biology. Viruses (2014) 0.76
Assessing parallel gene histories in viral genomes. BMC Evol Biol (2016) 0.76
Protein abundance may regulate sensitivity to external cues in polarized cells. J R Soc Interface (2015) 0.75
The ubiquitin system. Annu Rev Biochem (1998) 43.36
Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science (1986) 15.84
Aggresomes: a cellular response to misfolded proteins. J Cell Biol (1998) 11.24
PEST sequences and regulation by proteolysis. Trends Biochem Sci (1996) 8.90
Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev (1997) 5.22
Transformation and replication in mouse cells of a bovine papillomavirus--pML2 plasmid vector that can be rescued in bacteria. Proc Natl Acad Sci U S A (1982) 5.22
Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science (1990) 4.92
Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol (1996) 4.56
Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc Natl Acad Sci U S A (1995) 4.16
The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication. Cell (1993) 3.68
The 68-kilodalton E1 protein of bovine papillomavirus is a DNA binding phosphoprotein which associates with the E2 transcriptional activator in vitro. J Virol (1991) 2.65
Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J (1996) 2.61
Segregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation. Proc Natl Acad Sci U S A (1998) 2.50
Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin. J Virol (1998) 2.35
Bovine papilloma virus-transformed cells contain multiple E2 proteins. Proc Natl Acad Sci U S A (1988) 2.29
Phosphorylation controls timing of Cdc6p destruction: A biochemical analysis. Mol Biol Cell (1999) 2.07
Intracellular localization of proteasomal degradation of a viral antigen. J Cell Biol (1999) 2.04
Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. EMBO J (1996) 2.03
Acidic transcription factors alleviate nucleosome-mediated repression of DNA replication of bovine papillomavirus type 1. Proc Natl Acad Sci U S A (1994) 1.98
Transcription factor E2 regulates BPV-1 DNA replication in vitro by direct protein-protein interaction. Cold Spring Harb Symp Quant Biol (1991) 1.67
Phosphorylation sites of the E2 transcriptional regulatory proteins of bovine papillomavirus type 1. J Virol (1989) 1.65
The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain. J Biol Chem (1999) 1.59
A PEST-like sequence mediates phosphorylation and efficient ubiquitination of yeast uracil permease. Mol Cell Biol (1998) 1.58
The C terminus of mouse ornithine decarboxylase confers rapid degradation on dihydrofolate reductase. Support for the pest hypothesis. J Biol Chem (1991) 1.44
Bovine papillomavirus with a mutation in the E2 serine 301 phosphorylation site replicates at a high copy number. J Virol (1991) 1.22
Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein. EMBO J (1997) 1.20
A papillomavirus E2 phosphorylation mutant exhibits normal transient replication and transcription but is defective in transformation and plasmid retention. J Virol (1997) 1.17
Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required. Mol Cell Biol (1996) 1.17
The measurement of ubiquitin and ubiquitinated proteins. Electrophoresis (1999) 1.10
Residues phosphorylated by TFIIH are required for E2F-1 degradation during S-phase. EMBO J (1999) 1.04
Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin. J Virol (1998) 2.35
Suppression of cellular proliferation by the papillomavirus E2 protein. J Virol (1995) 2.05
Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J Virol (2006) 1.92
Binding of bovine papillomavirus E1 to the origin is not sufficient for DNA replication. Virology (1993) 1.79
Interaction of the papillomavirus E2 protein with mitotic chromosomes. Virology (2000) 1.74
Functional analysis of the papilloma virus E2 trans-activator in Saccharomyces cerevisiae. Genes Dev (1989) 1.40
Separation of the transcriptional activation and replication functions of the bovine papillomavirus-1 E2 protein. EMBO J (1992) 1.31
Identification of an Epstein-Barr virus-coded thymidine kinase. EMBO J (1986) 1.31
Domains of the BPV-1 E1 replication protein required for origin-specific DNA binding and interaction with the E2 transactivator. Virology (1995) 1.24
The bovine papillomavirus type 1 E2 transactivator and repressor proteins use different nuclear localization signals. J Virol (1996) 1.20
Amino acids critical for the functions of the bovine papillomavirus type 1 E2 transactivator. J Virol (1996) 1.14
The transactivation and DNA binding domains of the BPV-1 E2 protein have different roles in cooperative origin binding with the E1 protein. Virology (1996) 1.13
Transient viral DNA replication and repression of viral transcription are supported by the C-terminal domain of the bovine papillomavirus type 1 E1 protein. J Virol (1998) 0.82
Papillomavirus DNA replication. Methods Mol Med (2000) 0.75